bioAffinity Technologies (BIAFW) Total Liabilities (2021 - 2026)

bioAffinity Technologies has disclosed Total Liabilities across 6 years of filings, most recently posting $4.3 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 4.28% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (up 4.28% YoY), while the FY2025 annual figure was $3.7 million, down 5.84% from the prior year.
• Total Liabilities grew to $4.3 million in Q1 2026, from $3.7 million in the prior quarter.
• Over the last five years, Total Liabilities for BIAFW reached as high as $16.8 million in Q2 2022 and fell as low as $775151.0 in Q2 2023.
• The 5-year median for Total Liabilities is $3.4 million (2023), against an average of $4.7 million.
• Annual changes were most pronounced in 2023 — Total Liabilities slumped 95.38% — and 2024, when it jumped 315.83%.
• A 5-year view of Total Liabilities shows it stood at $1.1 million in 2022, then surged by 195.63% to $3.4 million in 2023, then gained by 16.2% to $3.9 million in 2024, then fell by 5.84% to $3.7 million in 2025, then grew by 16.31% to $4.3 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $4.3 million, $3.7 million, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.